alexa Structural Insights Into Antibiotic Action On The Ribosome
ISSN: 2155-9597

Journal of Bacteriology & Parasitology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Congress on Bacteriology & Infectious Diseases
November 17-19, 2014 DoubleTree by Hilton Hotel Chicago-North Shore, USA

Andrei A Korostelev
ScientificTracks Abstracts: J Bacteriol Parasitol
DOI: 10.4172/2155-9597.S1.006
Abstract
The ribosome is a cellular ribonucleoprotein machine responsible for protein synthesis. Due to its central role in a cell, the ribosome is a target of a large number of antibiotics. Understanding the molecular mechanisms, by which antibiotics inhibit translation, is of key importance for elucidating the bases of antibiotic resistance and developing novel antibacterial and antifungal therapeutics. Biochemical methods and X-ray crystallography were applied to gain high-resolution insights in the mechanisms of antibiotic action. Since the appearance of first crystal structures of ribosomal subunits, several mechanistic strategies used by antibiotics have been discovered. The most frequent strategy involves direct blocking of the polypeptide exit tunnel or of the binding sites of tRNAs and other extraribosomal factors involved in translation. Here in this talk, the author will discuss novel structural strategies involving the allosteric action of antibiotics, which may provide insights into development of new potent drugs.
Biography
Andrei A Korostelev obtained his PhD from Florida State University in 2003. He then moved to Santa Cruz, CA to pursue Postdoctoral studies in the laboratory of Harry F Noller. In 2010, he established a laboratory at the RNA Therapeutics Institute and Department of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School. He uses biochemical approaches and X-ray crystallography to study the mechanisms of protein synthesis on the ribosome and regulation of translation. His work resulted in more than twenty highly cited manuscripts published in Nature, Cell, PNAS, EMBO Journal, and other reputable journals. He serves as an editorial board member of Biochimie.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords